New onset-depression after RA diagnosis raises mortality risk ‘more than sixfold’June 15, 2022Rheumatoid Arthritis
Autoimmune disease linked to better late-stage breast cancer survivalJune 14, 2022Lupus & Connective Tissue DiseasesRheumatoid Arthritis
‘Encouraging’ results of baricitinib in juvenile idiopathic arthritisJune 5, 2022PediatricsRheumatoid ArthritisMixed Topics
Think it’s ILD? Tell it to the machinesJune 3, 2022Mixed TopicsRheumatoid ArthritisLupus & Connective Tissue Diseases
EULAR recommends starting methotrexate and glucocorticoids in RA managementJune 3, 2022Rheumatoid Arthritis
Abortion debate may affect Rx decisions for pregnant womenMay 27, 2022Lupus & Connective Tissue DiseasesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
‘Shielding’ status provides best indicator of COVID-19 mortality in U.K. arthritis populationMay 16, 2022COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
‘Goodie bag’ pill mill doctor sentenced to 2 decades in prisonMay 12, 2022Business of MedicinePainOsteoarthritisRheumatoid Arthritis
Reduced-frequency methotrexate monitoring causes no harmMay 10, 2022Rheumatoid ArthritisPsoriatic Arthritis
Upadacitinib earns FDA approval for ankylosing spondylitis May 2, 2022Ankylosing spondylitisPsoriatic ArthritisRheumatoid ArthritisSpondyloarthropathies
Parents’ autoimmune diseases may affect children’s developmentMay 2, 2022Psoriatic ArthritisRheumatoid Arthritis